SCHEMBL20652759

SCHEMBL20652759

CCn1c(=O)[nH]c(=O)c2c1nc(-c1nccnc1Cl)n2Cc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.57
▸ KMT2A Q03164 4/20 0.57
▸ KDM4E B2RXH2 7/20 0.57
▸ TSHR P16473 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ HSD17B10 Q99714 1/20 0.57
▸ ALDH1A1 P00352 6/20 0.55
▸ MAPT P10636 3/20 0.55
▸ PKM P14618 2/20 0.55
▸ MCL1 Q07820 2/20 0.55
▸ HTT P42858 2/20 0.54
▸ HPGD P15428 2/20 0.54
▸ GAA P10253 1/20 0.54
▸ TPH2 Q8IWU9 9/20 0.54
▸ TPH1 P17752 8/20 0.54
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ BRD4 O60885 1/20 0.52
▸ POLB P06746 2/20 0.50
▸ RECQL P46063 1/20 0.49
▸ BLM P54132 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20652779 0.87 ALDH1A1 (0.50) MEN1KMT2AKDM4ETSHRNPSR1
SCHEMBL22109760 0.83 KDM4E (0.57) MEN1KMT2AKDM4ETSHRNPSR1
SCHEMBL20652970 0.81 ATM (0.62) MEN1KMT2ATSHRHSD17B10ALDH1A1
SCHEMBL22105477 0.81 MEN1 (0.68) MEN1KMT2AKDM4ETSHRNPSR1
SCHEMBL22109758 0.81 KDM4E (0.56) MEN1KMT2AKDM4ETSHRNPSR1
SCHEMBL22109856 0.80 MEN1 (0.56) MEN1KMT2AKDM4ETSHRNPSR1
SCHEMBL22105772 0.80 KDM4E (0.61) MEN1KMT2AKDM4ETSHRNPSR1
SCHEMBL22105458 0.79 KDM4E (0.57) MEN1KMT2AKDM4ETSHRNPSR1
SCHEMBL22109617 0.76 BRD4 (0.53) MEN1KMT2AKDM4ETSHRNPSR1
SCHEMBL21389577 0.73 MEN1 (1.00) MEN1KMT2AKDM4ETSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3652176-B1 SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INT (DE) 2021-12-15 — — EP disclosed
US-10329292-B2 Substituted xanthine derivatives BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-06-25 — — US disclosed
WO-2019011802-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-01-17 — — WO disclosed
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329292-B2 Substituted xanthine derivatives TRPC5, TRPV1, TRPC4 MEN1 4272/4885KMT2A 4180/4885KDM4E 3884/4885
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES TRPC5, TRPC4, TRPV1 MEN1 4447/4885KMT2A 4155/4885KDM4E 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback